États-Unis · Bourse & Finance · Washington Post Business

Health Brief: Eli Lilly takes on retatrutide copycats

Publié par Washington Post Business · États-Unis il y a 16 h

Eli Lilly is suing five more companies accused of selling illicit copies of its experimental weight loss drug retatrutide as CEO Dave Ricks presses regulators to do more Insurers…

Lire l'article complet sur Washington Post Business Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.washingtonpost.com)

Health Brief: Eli Lilly takes on retatrutide copycats

À lire aussi

XRP Ledger patched decade-old bug that could create billions of dollars in XRP from nothing

Trump's AI rebrand is catching on with Elon Musk and Marc Benioff

Elon Musk intensifies attack on Ambani over Starlink India launch delay

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Big Controversy Upends a Contest About Microscopic Videos

Health Brief: Eli Lilly takes on retatrutide copycats

Partager

À lire aussi

XRP Ledger patched decade-old bug that could create billions of dollars in XRP from nothing

Trump's AI rebrand is catching on with Elon Musk and Marc Benioff

Elon Musk intensifies attack on Ambani over Starlink India launch delay

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Big Controversy Upends a Contest About Microscopic Videos